United States Eventing Association

From veterinarians to trainers to farriers, everyone in your stable of people helps make the ride more enjoyable—and longer-lasting.

Proactive wellness care may help horses—and their joints—move comfortably into their golden years, extending their careers and your opportunity for companionship.

The United States Eventing Association, Inc. (USEA) is happy to announce that long-time partner American Regent Animal Health, makers of Adequan® i.m. (polysulfated glycosaminoglycan), will continue their support of the USEA in 2023. Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final and a Contributing Sponsor of the USEA American Eventing Championships (AEC). The $60,000 Adequan® USEA Advanced Final will take place during the 2023 AEC at the Kentucky Horse Park in Lexington, Kentucky, this Aug. 29 through Sept. 3.

Estimates indicate up to 60 percent of lameness in the horse is related to end-stage degenerative joint disease (DJD), also known as osteoarthritis (OA). DJD can influence performance and significantly impact any horse—from top competitors and weekend warriors to aging seniors.

Mobility matters, so help keep your horse moving with healthy joints and smart healthcare. Lameness. A dreaded word. Uttering it means that your horse may be out of commission. Determining the cause can be challenging, which means treatment—and recovery—can be a long process.

From proven arthritis medications to nutritional supplements, understanding the differences among joint product types can make a real difference in your horse’s long-term mobility. Just like horses are similar but different, so are equine joint products. They’re created in different ways, approved for different uses and monitored differently for safety and effectiveness. Choosing the product (or products) right for your horse can be complex. The decision depends on a number of factors, like the condition affecting your horse’s joints, your horse’s severity of lameness or degenerative joint disease (DJD), the type of work your horse does, and the list goes on.

Adequan^® returns as The Official Joint Therapy Treatment of the USEA and Title Sponsor of the $60,000 Adequan^® USEA Advanced Final for 2022.

The 2021 USEA American Eventing Championships (AEC) presented by Nutrena Feeds is one of the most exciting events of the year thanks in great part to sponsor involvement. With the help of this year's amazing roster of sponsors, the AEC is proud to offer over $100,000 in prize money and numerous prizes to be awarded through sixth place across each of the 23 divisions! Many of this year’s AEC sponsors will be on-site at the Kentucky Horse Park throughout the duration of the 2021 Championships and will offer great goodies and some special offers for those in attendance this year.

The United States Eventing Association (USEA) is thrilled to announce the renewed partnership with longtime supporter American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan).

Active horses need healthy cartilage to maintain joint function. In joints with degenerative joint disease, also known as osteoarthritis, the complex process of cartilage repair is unable to keep up with damage. This video from Adequan explains the process of cartilage breakdown and how Adequan can help reduce inflammation, restore joint lubrication, repair cartilage, and reverse the disease cycle.